ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009

NCI Offers Informations, Resources, To Industry.

April 6, 2001

HHS News: Leavitt Confirmed As HHS Secretary.

January 28, 2005

NCCN Updates Myeloma Clinical Practice Guidelines

September 26, 2003

Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia

May 25, 2007

Barbara Rimer Named NCAB Chairman; First Women Appointed To Lead Board

September 16, 1994